Phibro Animal Health (PAHC) Capital Expenditures Growth (3y) (2016 - 2026)
Phibro Animal Health (PAHC) Capital Expenditures Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.96 Bn | 43.00 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.23 Bn | 39.58 Bn | 2.15 Bn | -4.39% |
| 3 | Zoetis | 31.76 Bn | 30.08 Bn | 1.05 Bn | -11.01% |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn | -0.22% |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 34.19% |
| 6 | Viatris | 18.69 Bn | 17.81 Bn | 1.46 Bn | -8.00% |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | 4.68% |
| 8 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn | -7.72% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Phibro Animal Health | 1.44 Bn | 1.36 Bn | 125.68 Mn | 24.65% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -37.71% |
| Dec 31, 2025 | 44.61% |
| Sep 30, 2025 | -83.45% |
| Jun 30, 2025 | 37.36% |
| Mar 31, 2025 | -8.21% |
| Dec 31, 2024 | 0.57% |
| Sep 30, 2024 | 8.76% |
| Jun 30, 2024 | 38.26% |
| Mar 31, 2024 | -24.18% |
| Dec 31, 2023 | 296.66% |
| Sep 30, 2023 | -2.33% |
| Jun 30, 2023 | -30.67% |
| Mar 31, 2023 | 1,073.25% |
| Dec 31, 2022 | -56.80% |
| Sep 30, 2022 | 44.54% |
| Jun 30, 2022 | -40.04% |
| Mar 31, 2022 | 114.63% |
| Dec 31, 2021 | 159.80% |
| Sep 30, 2021 | 180.54% |
| Jun 30, 2021 | -78.39% |